Clinical

Articles

Launched in August, Zoryve is a once-daily, steroid-free cream and is the first topical PDE4 inhibitor approved to treat plaque psoriasis in patients 12 years of age or older.

Express Scripts Adds Zoryve to National Formulary

Dupixent is the first treatment approved to treat prurigo nodularis, a chronic skin disorder characterized by the presence of hard, itchy nodules.

FDA Approves Duxipent for Rare Skin Disorder

Commercial shipments are already under way of Cosette’s gel formulation of tazarotene to treat patients with acne and facial wrinkles.

FDA Approves First Generic of Tazorac Gel

Developed by Bristol Myers Squibb, Sotyktu is the first approved TYK2 inhibitor. It is expected to be available later this month.

FDA Approves First-in-Class Therapy for Psoriasis

The FDA is expected to make a decision on Pfizer’s ritlecitinib in the second quarter of 2023.

FDA, EMA Accept Submissions for Alopecia Therapy

Daxxify enters the injectable botulinum toxin market as a twice-a year treatment for frown lines.



FDA Approves Longer-Lasting Treatment for Frown Lines

Spevigo is a monoclonal antibody that inhibits interleukin-36 (IL-36) signaling approved to treat for adults with generalized pustular psoriasis flares.

FDA Approves Novel Treatment for Rare Type of Psoriasis Flare

Zoryve is a next-generation topical PDE4 inhibitor to treat adults and adolescents with plaque psoriasis.

Arcutis Launches Steroid-Free Psoriasis Therapy Zoryve

Zoryve, the first topical PDE4 inhibitor approved to treat patients with plaque psoriasis, will be available by mid-August.

FDA Approves Steroid-Free Zoryve for Plaque Psoriasis

Denise Myshko is your editorial contact for the Formulary Watch. She joined Formulary Watch as editor is June 2021 from Oncology Live. Prior to that, she was managing editor of PharmaVOICE, a trade publication in the pharmaceutical industry. Email: dmyshko@mjhlifesciences.com

Opzelura is first therapy approved to treat patients with vitiligo, a disease that causes the loss of skin color.

Dermatology